. higher nta? based on bhd performance, the trading portion of the portfolio has gone up around 20% since suspension, around 10% nta or $6 million JBFG has also gone up $12 million as per anouncement an increase of 30% or $18 million
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%